<DOC>
	<DOCNO>NCT02322294</DOCNO>
	<brief_summary>This study investigate effect 8 week supplementation Glucodia™ , glucose parameter , triglyceride body weight compare placebo . Half subject administer Glucodia™ , half receive placebo .</brief_summary>
	<brief_title>Investigating Effects Glucodia™ Glucose Parameters , Triglycerides Body Weight</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<criteria>Healthy male female adult , age 21 45 year BMI 25 kg/m2 40 kg/m2 ( inclusive ) Subjects Fasting Plasma Glucose 5.56mmol/L 6.94mmol/L ( 100mg/dL125mg/dL ) AND EITHER Fasting Insulin 60 pmol/L 180 pmol/L OR Triglycerides 1.36mmol/L 3.39 mmol/L ( 120mg/dL300mg/dL ) Subject child bear potential . Defined female hysterectomy oophorectomy , bilateral tubal ligation postmenopausal ( natural surgically &gt; 1 year since last menstruation ) . OR Female subject childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . Acceptable method birth control include : Hormonal contraceptive include oral contraceptive , hormone birth control patch ( Ortho Evra ) , vaginal contraceptive ring ( NuvaRing ) , injectable contraceptive ( DepoProvera , Lunelle ) , hormone implant ( Norplant System ) , Doublebarrier method ( condom spermicide diaphragm spermacide ) , Nonhormonal intrauterine device , Vasectomy partner , Nonheterosexual lifestyle Subjects plan change smoke habit trial period . Subjects normally active deem healthy Medical Director Subjects agree maintain current level activity throughout trial period . Subjects agree maintain current dietary habit throughout trial period . Subjects give voluntary , write , inform consent participate study . Subjects pregnant , breastfeed plan become pregnant throughout course study . Subjects Fasting Glucose &lt; 5.56 mmol/L &gt; 6.94 mmol/L Subjects Fasting Plasma Glucose 5.56 mmol/L 6.94 mmol/L DO NOT EITHER Fasting Insulin 60 pmol/L 180 pmol/L OR Triglycerides 1.35 mmol/L 3.39 mmol/L Subjects BMI &lt; 25 kg/m2 &gt; 40 kg/m2 Subjects experience weight loss gain great 4.5 kg ( approximately 10 lb ) past 3 month Subjects uncontrolled hypertension ( ≥ 140 mmHg ) Subjects major disease cardiovascular , renal , hepatic , gastrointestinal , pulmonary endocrine system History current diagnosis cancer ( except successfully treat basal cell carcinoma ) diagnose less 5 year prior screen . Subjects cancer full remission 5 year diagnosis acceptable Subjects neurological disorder significant psychiatric illness Subjects unstable thyroid disease Subjects immunocompromised ( HIV positive , antirejection medication , rheumatoid arthritis ) Subjects take medication natural health product intend management diabetes , dyslipidemia body weight within 3 month randomization . Subjects use illicit drug history alcohol drug abuse within past 6 month Subjects currently consume great 2 standard alcoholic drink per day . Subjects participate clinical research trial within 30 day prior randomization . Subjects allergy sensitivity investigational product ingredient . Subjects cognitively impaired and/or unable give inform consent Subjects abnormal laboratory result medical psychological condition , opinion Principle Investigator , may adversely affect subject ability complete study measure may pose significant risk subject</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Protein</keyword>
	<keyword>mung bean</keyword>
	<keyword>glucose</keyword>
	<keyword>triglyceride</keyword>
	<keyword>insulin</keyword>
	<keyword>body weight ,</keyword>
	<keyword>DXA scan</keyword>
</DOC>